TY - JOUR
T1 - Multiple determinants of splicing repression activity in the polypyrimidine tract binding proteins, PTBP1 and PTBP2
AU - Keppetipola, Niroshika M.
AU - Yeom, Kyu Hyeon
AU - Hernandez, Adrian L.
AU - Bui, Tessa
AU - Sharma, Shalini
AU - Black, Douglas L.
N1 - Funding Information:
We thank Chris W. Smith (Cambridge University) for the Raver1 antibody. This work was supported in part by National Institutes of Health Ruth L. Kirschstein National Research Service Award (NIH-NRSA; 1F32GM093533), a CSUPERB New Investigator Award to N.M.K., and NIH grants R01GM049662 (to D.L.B.) and R21CA170786 (to S.S). K.H.Y. was supported by a fellowship from UCLA Broad Stem Cell Research Center's Training Program.
Publisher Copyright:
© 2016 Keppetipola et al.
PY - 2016/8
Y1 - 2016/8
N2 - Most human genes generate multiple protein isoforms through alternative pre-mRNA splicing, but the mechanisms controlling alternative splicing choices by RNA binding proteins are not well understood. These proteins can have multiple paralogs expressed in different cell types and exhibiting different splicing activities on target exons. We examined the paralogous polypyrimidine tract binding proteins PTBP1 and PTBP2 to understand how PTBP1 can exhibit greater splicing repression activity on certain exons. Using both an in vivo coexpression assay and an in vitro splicing assay, we show that PTBP1 is more repressive than PTBP2 per unit protein on a target exon. Constructing chimeras of PTBP1 and 2 to determine amino acid features that contribute to their differential activity, we find that multiple segments of PTBP1 increase the repressive activity of PTBP2. Notably, when either RRM1 of PTBP2 or the linker peptide separating RRM2 and RRM3 are replaced with the equivalent PTBP1 sequences, the resulting chimeras are highly active for splicing repression. These segments are distinct from the known region of interaction for the PTBP1 cofactors Raver1 and Matrin3 in RRM2. We find that RRM2 of PTBP1 also increases the repression activity of an otherwise PTBP2 sequence, and that this is potentially explained by stronger binding by Raver1. These results indicate that multiple features over the length of the two proteins affect their ability to repress an exon.
AB - Most human genes generate multiple protein isoforms through alternative pre-mRNA splicing, but the mechanisms controlling alternative splicing choices by RNA binding proteins are not well understood. These proteins can have multiple paralogs expressed in different cell types and exhibiting different splicing activities on target exons. We examined the paralogous polypyrimidine tract binding proteins PTBP1 and PTBP2 to understand how PTBP1 can exhibit greater splicing repression activity on certain exons. Using both an in vivo coexpression assay and an in vitro splicing assay, we show that PTBP1 is more repressive than PTBP2 per unit protein on a target exon. Constructing chimeras of PTBP1 and 2 to determine amino acid features that contribute to their differential activity, we find that multiple segments of PTBP1 increase the repressive activity of PTBP2. Notably, when either RRM1 of PTBP2 or the linker peptide separating RRM2 and RRM3 are replaced with the equivalent PTBP1 sequences, the resulting chimeras are highly active for splicing repression. These segments are distinct from the known region of interaction for the PTBP1 cofactors Raver1 and Matrin3 in RRM2. We find that RRM2 of PTBP1 also increases the repression activity of an otherwise PTBP2 sequence, and that this is potentially explained by stronger binding by Raver1. These results indicate that multiple features over the length of the two proteins affect their ability to repress an exon.
KW - Alternative splicing
KW - RNA binding proteins
UR - http://www.scopus.com/inward/record.url?scp=84979675917&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84979675917&partnerID=8YFLogxK
U2 - 10.1261/rna.057505.116
DO - 10.1261/rna.057505.116
M3 - Article
C2 - 27288314
AN - SCOPUS:84979675917
SN - 1355-8382
VL - 22
SP - 1172
EP - 1180
JO - RNA
JF - RNA
IS - 8
ER -